Active, Not Recruiting
Phase 3
Age: 19Years - 76Years
All Genders
ID05937750
A Prospective, Post-authorisation Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation, Including a Non-comparative Concurrent Reference Cohort
Led by Hansa Biopharma AB · Updated on 2026-06-23
150
Participants Needed
14
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
A prospective, post-authorisation long-term follow-up trial of patients previously treated with imlifidase prior to kidney transplantation, including a non-comparative concurrent reference cohort.
CONDITIONS
Brief Title
A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here